?Vitamin D as add-on treatment for relapsing-remitting multiple sclero
?Vitamin D as add-on treatment for relapsing-remitting multiple sclerosis: an unicentric, randomized, double-blinded, placebo-controlled clinical trial?
What it found
We found no results in the registry or in papers.
What was tested
Treatment tested
- Cholecalciferol
Vitamin D receptor agonist
What it measured
Main measures
Main outcome: proportion of patients experiencing at least one relapse during the study period.
Relapses
Other measures (1)
- La tasa de brotes (número de brotes por unidad de tiempo)
Who could take part
Relapsing MS
Show the full criteria
Inclusion criteria
Inclusion: 1.Written informed consent must be optained before any assessment is performed. Exclusion: -History of allergy to vitamin D.
Exclusion criteria
Not separately supplied in the registry.
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
To study the effect of vitamin D3 versus placebo as an add-on treatment to the first-line disease modifying therapies for relapsing-remitting multiple sclerosis on the clinical activity, measured as the proportion of patients experiencing a relapse within the study period.
Loading reviews and guidelines…
Related trials
- Effect of Probiotics on Relapsing-Remitting Multiple Sclerosis
Not a drug-phase study · Completed
No results found
- Targeting the Gut Dysbiosis to Treat Inflammation-driven Synaptopathy
Not a drug-phase study · Status unknown
No results found
- Investigating the Effects of Hydroxyvitamin D3 on Multiple Sclerosis
Phase 4 · Status unknown
No results found
- Efficacy of Diet on Quality of Life in Multiple Sclerosis
Not a drug-phase study · Running, not recruiting
Still running
- Prebiotic vs Probiotic in Multiple Sclerosis
Not a drug-phase study · Completed
Paper found, not read
- Longitudinal Effect of Vitamin D3 Replacement on Cognitive Performance
Not a drug-phase study · Status unknown
No results found
History
Started
Nov 2012